Ranbaxy launches generic Lipitor in 4 EU markets

Tue Mar 6, 2012 2:22pm IST

Related Topics

Stocks

   

REUTERS - Group Ranbaxy Laboratories (RANB.NS) has launched generic copies of Lipitor in four European markets, bringing cheap versions of U.S. drugmaker Pfizer's blockbuster cholesterol drug to Germany, Italy, the Netherlands and Sweden.

The launch of a generic version of the largest-selling drug of all time came two months before patents expire in the four countries, following an agreement with Pfizer.

The drug went off patent in the United States at the end of November, marking a major milestone for a global pharmaceutical industry facing a wave of patent losses, of which Lipitor is the biggest.

Ranbaxy said on Tuesday it would sell 10, 20, 40 and 80 milligram tablets of the medicine, known generically as atorvastatin, in Germany, Italy and Sweden. The top 80 mg dose will not be available in the Netherlands.

Lipitor became available in 1997 and generated worldwide annual sales of $13 billion at its peak. It lowers "bad" LDL cholesterol and the risk of heart attack and stroke.

It has chalked up more than $130 billion in sales during its time on the market and many analysts doubt if another drug of its magnitude will be seen again, in part because drugmakers are moving to a model of more personalised medicine.

(Reporting by Ben Hirschler; Editing by Dan Lalor)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

World Bank Rival

World Bank Rival

Three major nations absent as China launches W.Bank rival in Asia  Full Article 

Kashmir Package

Kashmir Package

Modi announces relief package for flood-hit Kashmir.  Full Article 

Microsoft Earnings

Microsoft Earnings

Microsoft sales beat Street hopes, cloud profits up.  Full Article 

U.S. Economy

U.S. Economy

Spectre of no-inflation world looms over Fed's return to normal  Full Article 

Insider Trading

Insider Trading

Rengan Rajaratnam, SEC to settle civil insider trading charge.  Full Article 

Market Watch

Market Watch

Betting on the beaten up? Investors pin hopes on stocks in Europe, Japan.  Full Article 

India Insight

India Insight

Kalki Koechlin on her role as a disabled girl in “Margarita, With a Straw”  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage